Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ecopetrol SA

8.89
+0.09001.02%
Post-market: 8.980.0891+1.00%19:59 EDT
Volume:2.56M
Turnover:22.89M
Market Cap:18.28B
PE:5.40
High:9.16
Open:9.11
Low:8.78
Close:8.80
Loading ...

EC Healthcare Updates Hong Kong Share Registrar Name

TIPRANKS
·
20 Jan

EC World REIT Convenes Key Meeting to Discuss Strategic Directions

TIPRANKS
·
20 Jan

EC Healthcare Shareholders to Vote Feb. 5 on Sale, Purchase Contracts

MT Newswires Live
·
20 Jan

EC Healthcare Announces EGM for Key Acquisition and Disposal Agreements

TIPRANKS
·
20 Jan

ECOPETROL S.A. reports on the decision adopted by the Court of the Southern District of New York on the arbitration ruling issued in favor of Refinería de Cartagena S.A.S.

PR Newswire
·
17 Jan

InflaRx Stock Rises 8% on Conditional EC Nod for COVID-19 Drug

Zacks
·
16 Jan

Ecopetrol announces changes in senior management

PR Newswire
·
16 Jan

Ecopetrol agrees to temporary 50% cut in conversion cost for ADR purchase, sale

TIPRANKS
·
16 Jan

Ecopetrol agrees to a temporary 50% reduction in the conversion cost for the purchase and sale of its ADRs

PR Newswire
·
16 Jan

InflaRx announces EC grants marketing authorization to Gohibic for ARDS

TIPRANKS
·
16 Jan

InflaRx Receives European Commission Approval for GOHIBIC® (vilobelimab) for the Treatment of SARS-CoV-2-Induced Acute Respiratory Distress Syndrome (ARDS)

GlobeNewswire
·
16 Jan

EU Greenlights Synopsys’ (SNPS) $35B Ansys Deal with Conditions

TIPRANKS
·
13 Jan

Synopsys ‘very pleased’ EC has approved proposed acquisition of Ansys

TIPRANKS
·
11 Jan

Synopsys Responds to the European Commission Approving its Proposed Acquisition of Ansys in Phase 1

PR Newswire
·
11 Jan

Samsung Bioepis and Teva Enter into a Strategic Partnership for Commercialization of EPYSQLI® (eculizumab-aagh) in the United States

GlobeNewswire
·
10 Jan

Rhythm Pharmaceuticals Announces Preliminary Fourth Quarter and Full Year 2024 Net Product Revenues, Pipeline Advancements and Upcoming Milestones

GlobeNewswire
·
10 Jan

RARE's Cholesterol Drug Evkeeza Gains EC Approval for Expanded Use

Zacks
·
07 Jan

European Commission (EC) Extends the Approval of Evkeeza® (evinacumab) to Children as Young as 6-months Old with Homozygous Familial Hypercholesterolemia (HoFH)

GlobeNewswire
·
06 Jan

GeoPark's CPO-9 Block Acquisition Halted by Ecopetrol's Move

Zacks
·
02 Jan

Is Trending Stock Ecopetrol S.A. (EC) a Buy Now?

Zacks
·
01 Jan